PTPN22 is thought to regulate the observed anti-tumor immunity through its catalytic function based on the similar inhibition of Hepa1-6.x1 tumor growth observed with Ptpn22C227S inactive knock-in mice and PTPN22-deficient mice (75). The gene discussed is PTPN22; the disease is neoplasm.